Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00284180. Last updated on March 20, 2008.
Information provided by Sarah Cannon Research Institute
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Neoplasms
Breast Cancer
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Vinflunine
Herceptin
Additional drug interventions recognized in this trial
Trastuzumab
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sarah Cannon Research Institute
SCRI Oncology Research Consortium
Bristol-Myers Squibb
Back to top of Main Content